AMV564, a novel bivalent, bispecific T-cell engager, targets myeloid-derived suppressor cells

Eckard, S; Gehrs, L; Smith, V; Guenot, J; DiPersio, J; Wei, S; Rettig, M

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019; 7 ():

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索